Development of a natural nanostructured lipid carrier (NLC)-based delivery system as an antidiabetic and diabetic wound agent: A review
DOI:
https://doi.org/10.35335/midwifery.v13i5.2152Keywords:
Antidiabetic, Diabetic Wounds, Nanostructured Lipid Carrier, Natural IngredientsAbstract
Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia due to impaired insulin secretion. Diabetes often causes serious complications such as diabetic wounds, which are characterized by the appearance of ulcers, infections, or tissue damage in the feet. Conventional therapeutic approaches often show less than optimal effectiveness due to limited drug penetration into damaged skin tissue. The use of natural ingredients with antidiabetic and wound healing activities has been widely studied, but their effectiveness is often hampered by low solubility, stability, and bioavailability. One innovative strategy to overcome these problems is the development of nanotechnology-based drug delivery systems, one of which is Nanostructured Lipid Carrier (NLC). NLC is a lipid delivery system that combines solid and liquid lipids to increase stability, drug loading capacity, and control the release of active compounds. Purpose: This article aims to review the development of formulations from natural ingredients that have potential as antidiabetic and diabetic wound healing activities. Methods: This study is a literature review of articles published in the last ten years (2015 – 2025) from the ScienceDirect, PubMed, and Google Scholar databases. Results: Based on several studies, it shows that various active compounds such as curcumin (Curcuma longa), bay leaves (Syzygium polyanthum), and other flavonoid compounds have been formulated in the NLC system with significant improvements in stability, bioavailability, and pharmacological effectiveness. Conclusion: The NLC-based drug delivery system from natural ingredients has proven potential in increasing the effectiveness of antidiabetic therapy and diabetic wound healing. Further research is needed to optimize formulation stability, long-term toxicity testing, and clinical validation to support its therapeutic application.
Downloads
References
Abidin, Z. (2024). Kecemasan Dan Pengalaman Mengatasinya Pada Penyandang Ulkus Diabetikum Yang Menjalani Perawatan Di Rumah Sakit. Bookchapter Diabetes Mellitus.
Aspadiah, V., Fristiohady, A., & Wahyuningrum, S. N. (2020). Review artikel: penggunaan lipid asam stearat dalam sistem penghantaran obat berbasis nanopartikel. Media Farmasi, 16(2), 141–154.
Chiuman, L. (2024). MONOGRAF KHASIAT ANTIDIABETIK NANOEMULSI ANDALIMAN. PUBLIS PENERBIT UNPRI PRESS, 1(2).
Criollo-Mendoza, M. S., Contreras-Angulo, L. A., Leyva-López, N., Gutiérrez-Grijalva, E. P., Jiménez-Ortega, L. A., & Heredia, J. B. (2023). Wound healing properties of natural products: mechanisms of action. Molecules, 28(2), 598.
Evalina, M., & Aryani, N. L. D. (n.d.). Ulasan: Terapi Herbal untuk Penyembuhan Luka Ulkus Kaki Diabetik Review: Herbal Therapy for Diabetic Foot Ulcer Wound Healing.
Fauzian, F., Garmana, A. N., & Mauludin, R. (2024). The efficacy of carvacrol loaded nanostructured lipid carrier in improving the diabetic wound healing activity: In vitro and in vivo studies. Journal of Applied Pharmaceutical Science, 14(3), 231–243.
Federation, I. D. (2022). IDF diabetes atlas 10th edition. 2022-12-01)[2023-05-19]. Https://Diabetesatlas. Org.
Hayati, R., Sari, A. R. I. P., & Farm, S. (2024). INOVASI FORMULASI FARMASI: NANOTEKNOLOGI DAN BAHAN HERBAL. Nuansa Fajar Cemerlang.
Herman, A., & Herman, A. P. (2023). Herbal products and their active constituents for diabetic wound healingâ€â€ÂPreclinical and clinical studies: A systematic review. Pharmaceutics, 15(1), 281.
Huang, Y.-Y., Lin, C.-W., Cheng, N.-C., Cazzell, S. M., Chen, H.-H., Huang, K.-F., … Perng, C.-K. (2021). Effect of a novel macrophage-regulating drug on wound healing in patients with diabetic foot ulcers: a randomized clinical trial. JAMA Network Open, 4(9), e2122607–e2122607.
Ilyas, U., Asif, M., Wang, M., Altaf, R., Zafar, H., Faran Ashraf Baig, M. M., … Abbas, M. (2022). Nanostructured lipid carrier-based delivery of pioglitazone for treatment of type 2 diabetes. Frontiers in Pharmacology, 13, 934156.
Jafar, G., & Sutrisno, E. (2024). REVIEW ARTICLE LIPID-BASED NANOTECHNOLOGY. Medical Sains: Jurnal Ilmiah Kefarmasian, 9(1), 189–204.
Kambale, E. K., Quetin-Leclercq, J., Memvanga, P. B., & Beloqui, A. (2022). An overview of herbal-based antidiabetic drug delivery systems: focus on lipid-and inorganic-based nanoformulations. Pharmaceutics, 14(10), 2135.
Latifah, Z. A. (2024). Pengembangan Formula dan Karakterisasi Nanostructured Lipid Carriers (NLC) Kurkumin Menggunakan Gliceryl Palmitostreat, Capric Triglyceride, dan Decyl Glucoside. Universitas Bhakti Kencana.
Lee, H.-J., Jeong, M., Na, Y.-G., Kim, S.-J., Lee, H.-K., & Cho, C.-W. (2020). An EGF-and curcumin-co-encapsulated nanostructured lipid carrier accelerates chronic-wound healing in diabetic rats. Molecules, 25(20), 4610.
Maslachah, L. (2024). BENTUK SEDIAAN OBAT DAN PENERAPAN R/UNTUK VETERINER. Airlangga University Press.
Nugraha, R. (2024). Pengembangan FOrmulasi dan Karakterisasi Nanostructured Lipid Carriers (NCL) Kurkumin Menggunakan Peg-8 Beeswax, Capric. Universitas Bhakti Kencana.
Putra, K. D. A., Pradnyaswari, G. A. D., & Setyawan, E. I. (2022). Potensi Nanostructured Lipid Carrier (NLC) dengan zat aktif ekstrak herba Pegagan (Centella asiatica (L.) Urb.) sebagai sediaan topical gel anti-photoaging. In Prosiding Workshop dan Seminar Nasional Farmasi (Vol. 1, pp. 295–312).
Qushawy, M., Alanazi, M. A., Hikal, W. M., Amirthalingam, P., Abu-Gharbieh, E., Almanzalawi, W. S., … Elsherbini, A. M. (2025). Optimized Nanostructured Lipid Carriers for Metformin: Enhanced Anti-Inflammatory Activity and Protection Against Type 2 Diabetes-Induced Organ Damage. International Journal of Nanomedicine, 3765–3788.
Rismawati, R., Gondokesumo, M. E., & Aryani, N. L. D. (2025). Ulasan: Terapi Herbal untuk Penyembuhan Luka Ulkus Kaki Diabetik (Review: Herbal Therapy for Diabetic Foot Ulcer Wound Healing). Jurnal Surya Medika (JSM), 11(1), 1–16.
Shiyan, S. (2021). Teknologi Fitofarmasetika: Sistem Pembawa Katekin dan EGCG pada Terapi Diabetes. Deepublish.
SURYANI, M. E. I. L. (n.d.). KARAKTERISASI SIFAT FISIKOKIMIA DAN MORFOLOGI NANOSTRUCTURED LIPID CARRIER (NLC) BERMUATAN EKSTRAK TEMULAWAK (Curcuma xanthorrhiza Roxb).
Wathoni, N., Suhandi, C., Elamin, K. M., Lesmana, R., Hasan, N., Mohammed, A. F. A., … Wilar, G. (2024). Advancements and challenges of nanostructured lipid carriers for wound healing applications. International Journal of Nanomedicine, 8091–8113.
Zubir, A. F., Brisma, S., Zulkarnaini, A., & Anissa, M. (2024). Gambaran Penderita Ulkus Diabetikum yang Menjalani Tindakan Operasi. Scientific Journal, 3(4), 232–241.
